Mirum Pharmaceuticals, Inc. (MIRM) has a market capitalization of $4.86B and trades at $96.90. The 52-week range is 36.88-109.28.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -206.2, Earnings Per Share (EPS) of $-0.47, annual revenue of $521.31M.
The stock has a beta of 0.52, operates in the Healthcare sector.
